Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-10-30

AUTHORS

Eline H. Ploumen, Tineke H. Pinxterhuis, Paolo Zocca, Ariel Roguin, Rutger L. Anthonio, Carl E. Schotborgh, Edouard Benit, Adel Aminian, Peter W. Danse, Carine J. M. Doggen, Clemens von Birgelen, Marlies M. Kok

ABSTRACT

BackgroundDiabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treated with contemporary stents, bleeding data are lacking. We assessed 3-year ischemic and bleeding outcomes following treatment with new-generation DES in patients with prediabetes and diabetes as compared to normoglycemia.MethodsFor this post-hoc analysis, we pooled patient-level data of the BIO-RESORT and BIONYX stent trials which both stratified for diabetes at randomization. Both trials were multicenter studies performed in tertiary cardiac centers. Study participants were patients of whom glycemic state was known based on hemoglobin A1c, fasting plasma glucose, or medically treated diabetes. Three-year follow-up was available in 4212/4330 (97.3 %) patients. The main endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization.ResultsBaseline cardiovascular risk profiles were progressively abnormal in patients with normoglycemia, prediabetes, and diabetes. The main endpoint occurred in 54/489 patients with prediabetes (11.2 %) and 197/1488 with diabetes (13.7 %), as compared to 142/2,353 with normoglycemia (6.1 %) (HR: 1.89, 95 %-CI 1.38–2.58, p < 0.001, and HR: 2.30, 95 %-CI 1.85–2.86, p < 0.001, respectively). In patients with prediabetes, cardiac death and target vessel revascularization rates were significantly higher (HR: 2.81, 95 %-CI 1.49–5.30, p = 0.001, and HR: 1.92, 95 %-CI 1.29–2.87, p = 0.001), and in patients with diabetes all individual components of the main endpoint were significantly higher than in patients with normoglycemia (all p ≤ 0.001). Results were consistent after adjustment for confounders. Major bleeding rates were significantly higher in patients with prediabetes and diabetes, as compared to normoglycemia (3.9 % and 4.1 % vs. 2.3 %; HR:1.73, 95 %-CI 1.03–2.92, p = 0.040, and HR:1.78, 95 %-CI 1.23–2.57, p = 0.002). However, after adjustment for confounders, differences were no longer significant.ConclusionsNot only patients with diabetes but also patients with prediabetes represent a high-risk population. After treatment with new-generation DES, both patient groups had higher risks of ischemic and bleeding events. Differences in major bleeding were mainly attributable to dissimilarities in baseline characteristics. Routine assessment of glycemic state may help to identify patients with prediabetes for intensified management of cardiovascular risk factors.Trial registration: BIO-RESORT ClinicalTrials.gov: NCT01674803, registered 29-08-2012; BIONYX ClinicalTrials.gov: NCT02508714, registered 27-7-2015. More... »

PAGES

217

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4

DOI

http://dx.doi.org/10.1186/s12933-021-01405-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142277542

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34717627


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Thrombosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Percutaneous Coronary Intervention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prediabetic State", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ploumen", 
        "givenName": "Eline H.", 
        "id": "sg:person.015002444531.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015002444531.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pinxterhuis", 
        "givenName": "Tineke H.", 
        "id": "sg:person.012437210704.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012437210704.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zocca", 
        "givenName": "Paolo", 
        "id": "sg:person.07360604275.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07360604275.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel", 
          "id": "http://www.grid.ac/institutes/grid.6451.6", 
          "name": [
            "Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roguin", 
        "givenName": "Ariel", 
        "id": "sg:person.0624615067.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624615067.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.491363.a", 
          "name": [
            "Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anthonio", 
        "givenName": "Rutger L.", 
        "id": "sg:person.0727014624.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727014624.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Haga Hospital, The Hague, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.413591.b", 
          "name": [
            "Department of Cardiology, Haga Hospital, The Hague, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schotborgh", 
        "givenName": "Carl E.", 
        "id": "sg:person.0634373652.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634373652.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Jessa Hospital, Hasselt, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.414977.8", 
          "name": [
            "Department of Cardiology, Jessa Hospital, Hasselt, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benit", 
        "givenName": "Edouard", 
        "id": "sg:person.0730262371.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730262371.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.413871.8", 
          "name": [
            "Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aminian", 
        "givenName": "Adel", 
        "id": "sg:person.01240141422.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240141422.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415930.a", 
          "name": [
            "Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Danse", 
        "givenName": "Peter W.", 
        "id": "sg:person.0752260563.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260563.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doggen", 
        "givenName": "Carine J. M.", 
        "id": "sg:person.01146757520.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Birgelen", 
        "givenName": "Clemens", 
        "id": "sg:person.0600054325.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kok", 
        "givenName": "Marlies M.", 
        "id": "sg:person.0660011420.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00592-015-0746-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039151013", 
          "https://doi.org/10.1007/s00592-015-0746-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40256-018-0295-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106283437", 
          "https://doi.org/10.1007/s40256-018-0295-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12933-020-01173-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132950023", 
          "https://doi.org/10.1186/s12933-020-01173-7"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-10-30", 
    "datePublishedReg": "2021-10-30", 
    "description": "BackgroundDiabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treated with contemporary stents, bleeding data are lacking. We assessed 3-year ischemic and bleeding outcomes following treatment with new-generation DES in patients with prediabetes and diabetes as compared to normoglycemia.MethodsFor this post-hoc analysis, we pooled patient-level data of the BIO-RESORT and BIONYX stent trials which both stratified for diabetes at randomization. Both trials were multicenter studies performed in tertiary cardiac centers. Study participants were patients of whom glycemic state was known based on hemoglobin A1c, fasting plasma glucose, or medically treated diabetes. Three-year follow-up was available in 4212/4330 (97.3\u2009%) patients. The main endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization.ResultsBaseline cardiovascular risk profiles were progressively abnormal in patients with normoglycemia, prediabetes, and diabetes. The main endpoint occurred in 54/489 patients with prediabetes (11.2\u2009%) and 197/1488 with diabetes (13.7\u2009%), as compared to 142/2,353 with normoglycemia (6.1\u2009%) (HR: 1.89, 95\u2009%-CI 1.38\u20132.58, p\u00a0<\u00a00.001, and HR: 2.30, 95\u2009%-CI 1.85\u20132.86, p\u00a0<\u00a00.001, respectively). In patients with prediabetes, cardiac death and target vessel revascularization rates were significantly higher (HR: 2.81, 95\u2009%-CI 1.49\u20135.30, p\u00a0=\u00a00.001, and HR: 1.92, 95\u2009%-CI 1.29\u20132.87, p\u00a0=\u00a00.001), and in patients with diabetes all individual components of the main endpoint were significantly higher than in patients with normoglycemia (all p\u00a0\u2264\u00a00.001). Results were consistent after adjustment for confounders. Major bleeding rates were significantly higher in patients with prediabetes and diabetes, as compared to normoglycemia (3.9\u2009% and 4.1\u2009% vs. 2.3\u2009%; HR:1.73, 95\u2009%-CI 1.03\u20132.92, p\u00a0=\u00a00.040, and HR:1.78, 95\u2009%-CI 1.23\u20132.57, p\u00a0=\u00a00.002). However, after adjustment for confounders, differences were no longer significant.ConclusionsNot only patients with diabetes but also patients with prediabetes represent a high-risk population. After treatment with new-generation DES, both patient groups had higher risks of ischemic and bleeding events. Differences in major bleeding were mainly attributable to dissimilarities in baseline characteristics. Routine assessment of glycemic state may help to identify patients with prediabetes for intensified management of cardiovascular risk factors.Trial registration: BIO-RESORT ClinicalTrials.gov: NCT01674803, registered 29-08-2012; BIONYX ClinicalTrials.gov: NCT02508714, registered 27-7-2015.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12933-021-01405-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031021", 
        "issn": [
          "1475-2840"
        ], 
        "name": "Cardiovascular Diabetology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "keywords": [
      "new-generation drug-eluting stents", 
      "drug-eluting stents", 
      "main endpoint", 
      "cardiac death", 
      "glycemic state", 
      "target vessel myocardial infarction", 
      "vessel revascularization rate", 
      "major bleeding rates", 
      "impact of prediabetes", 
      "tertiary cardiac centre", 
      "target vessel failure", 
      "vessel myocardial infarction", 
      "cardiovascular risk profile", 
      "cardiovascular risk factors", 
      "percutaneous coronary intervention", 
      "high-risk population", 
      "patient-level data", 
      "BIO-RESORT", 
      "major bleeding", 
      "vessel revascularization", 
      "revascularization rates", 
      "coronary intervention", 
      "baseline characteristics", 
      "cardiac center", 
      "hemoglobin A1c", 
      "multicenter study", 
      "patient group", 
      "adverse outcomes", 
      "stent trials", 
      "plasma glucose", 
      "myocardial infarction", 
      "bleeding rate", 
      "risk factors", 
      "clinical trials", 
      "prediabetes", 
      "high risk", 
      "patients", 
      "diabetes", 
      "normoglycemia", 
      "routine assessment", 
      "study participants", 
      "risk profile", 
      "stents", 
      "trials", 
      "endpoint", 
      "three years", 
      "confounders", 
      "outcomes", 
      "contemporary stents", 
      "death", 
      "vessel failure", 
      "treatment", 
      "BackgroundDiabetes", 
      "revascularization", 
      "A1C", 
      "bleeding", 
      "infarction", 
      "adjustment", 
      "intervention", 
      "MethodsFor", 
      "differences", 
      "risk", 
      "randomization", 
      "association", 
      "ConclusionsNot", 
      "glucose", 
      "rate", 
      "participants", 
      "failure", 
      "group", 
      "population", 
      "assessment", 
      "management", 
      "factors", 
      "data", 
      "center", 
      "study", 
      "individual components", 
      "events", 
      "profile", 
      "impact", 
      "analysis", 
      "results", 
      "characteristics", 
      "state", 
      "components", 
      "dissimilarity", 
      "composites"
    ], 
    "name": "Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials", 
    "pagination": "217", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142277542"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12933-021-01405-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34717627"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12933-021-01405-4", 
      "https://app.dimensions.ai/details/publication/pub.1142277542"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_897.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12933-021-01405-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'


 

This table displays all metadata directly associated to this object as RDF triples.

347 TRIPLES      21 PREDICATES      138 URIs      126 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12933-021-01405-4 schema:about N017fea96af404975ac102b1c7fda11c8
2 N084013bbefd44d28a382433244543958
3 N10e90714fb7144fbb0f492dd98ef4c10
4 N275d1b13ff7346e3aee69a982ae81778
5 N2873c3e0e6be465fafc2d3b3431ca390
6 N2886f262bb7b424da58282bd06aaf8b5
7 N330cf17e2de5492dbb6adf7bb1aef47f
8 N3931e43d1f554acdbfae5eba5041939e
9 N3bf98fe86438447983f75d3b6cff545d
10 N3fa16763c3a4454082c021ebc9cd673c
11 N4e775834692b437380861eb80ff8a7b8
12 N67bc17f9850447fda59d5de023b9c333
13 N8a3cb52baa4f4a5cb1708ccb25e3b8aa
14 Na3928d2c25e94be0ac1c31cdd50c4d28
15 Naf3dfdffea5b45089b83d7763ccb0017
16 Nb7906a90eff441b3a9a71e1e663fa7b9
17 Ndbdf9624e6f0489eb3e4dee35bf43d10
18 Nde05527cbefb4630b37c0a18ea479592
19 Ne65afba2f7eb4b79b1922cc431c566db
20 Nea2e020e22dc46cb901a1c0c75721c2e
21 Nf519c9f474fe41a48f0b5951a697f4c3
22 anzsrc-for:11
23 anzsrc-for:1102
24 anzsrc-for:1103
25 schema:author Ne568574688064c5498905012e402e975
26 schema:citation sg:pub.10.1007/s00592-015-0746-8
27 sg:pub.10.1007/s40256-018-0295-y
28 sg:pub.10.1186/s12933-020-01173-7
29 schema:datePublished 2021-10-30
30 schema:datePublishedReg 2021-10-30
31 schema:description BackgroundDiabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treated with contemporary stents, bleeding data are lacking. We assessed 3-year ischemic and bleeding outcomes following treatment with new-generation DES in patients with prediabetes and diabetes as compared to normoglycemia.MethodsFor this post-hoc analysis, we pooled patient-level data of the BIO-RESORT and BIONYX stent trials which both stratified for diabetes at randomization. Both trials were multicenter studies performed in tertiary cardiac centers. Study participants were patients of whom glycemic state was known based on hemoglobin A1c, fasting plasma glucose, or medically treated diabetes. Three-year follow-up was available in 4212/4330 (97.3 %) patients. The main endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization.ResultsBaseline cardiovascular risk profiles were progressively abnormal in patients with normoglycemia, prediabetes, and diabetes. The main endpoint occurred in 54/489 patients with prediabetes (11.2 %) and 197/1488 with diabetes (13.7 %), as compared to 142/2,353 with normoglycemia (6.1 %) (HR: 1.89, 95 %-CI 1.38–2.58, p < 0.001, and HR: 2.30, 95 %-CI 1.85–2.86, p < 0.001, respectively). In patients with prediabetes, cardiac death and target vessel revascularization rates were significantly higher (HR: 2.81, 95 %-CI 1.49–5.30, p = 0.001, and HR: 1.92, 95 %-CI 1.29–2.87, p = 0.001), and in patients with diabetes all individual components of the main endpoint were significantly higher than in patients with normoglycemia (all p ≤ 0.001). Results were consistent after adjustment for confounders. Major bleeding rates were significantly higher in patients with prediabetes and diabetes, as compared to normoglycemia (3.9 % and 4.1 % vs. 2.3 %; HR:1.73, 95 %-CI 1.03–2.92, p = 0.040, and HR:1.78, 95 %-CI 1.23–2.57, p = 0.002). However, after adjustment for confounders, differences were no longer significant.ConclusionsNot only patients with diabetes but also patients with prediabetes represent a high-risk population. After treatment with new-generation DES, both patient groups had higher risks of ischemic and bleeding events. Differences in major bleeding were mainly attributable to dissimilarities in baseline characteristics. Routine assessment of glycemic state may help to identify patients with prediabetes for intensified management of cardiovascular risk factors.Trial registration: BIO-RESORT ClinicalTrials.gov: NCT01674803, registered 29-08-2012; BIONYX ClinicalTrials.gov: NCT02508714, registered 27-7-2015.
32 schema:genre article
33 schema:isAccessibleForFree true
34 schema:isPartOf N7438392cb38d46008a43644962417938
35 N7dfb00bf94914bc1b89a79b3bee6ee31
36 sg:journal.1031021
37 schema:keywords A1C
38 BIO-RESORT
39 BackgroundDiabetes
40 ConclusionsNot
41 MethodsFor
42 adjustment
43 adverse outcomes
44 analysis
45 assessment
46 association
47 baseline characteristics
48 bleeding
49 bleeding rate
50 cardiac center
51 cardiac death
52 cardiovascular risk factors
53 cardiovascular risk profile
54 center
55 characteristics
56 clinical trials
57 components
58 composites
59 confounders
60 contemporary stents
61 coronary intervention
62 data
63 death
64 diabetes
65 differences
66 dissimilarity
67 drug-eluting stents
68 endpoint
69 events
70 factors
71 failure
72 glucose
73 glycemic state
74 group
75 hemoglobin A1c
76 high risk
77 high-risk population
78 impact
79 impact of prediabetes
80 individual components
81 infarction
82 intervention
83 main endpoint
84 major bleeding
85 major bleeding rates
86 management
87 multicenter study
88 myocardial infarction
89 new-generation drug-eluting stents
90 normoglycemia
91 outcomes
92 participants
93 patient group
94 patient-level data
95 patients
96 percutaneous coronary intervention
97 plasma glucose
98 population
99 prediabetes
100 profile
101 randomization
102 rate
103 results
104 revascularization
105 revascularization rates
106 risk
107 risk factors
108 risk profile
109 routine assessment
110 state
111 stent trials
112 stents
113 study
114 study participants
115 target vessel failure
116 target vessel myocardial infarction
117 tertiary cardiac centre
118 three years
119 treatment
120 trials
121 vessel failure
122 vessel myocardial infarction
123 vessel revascularization
124 vessel revascularization rate
125 schema:name Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
126 schema:pagination 217
127 schema:productId N851a308fa258453a9cd5d68a0bb0c46e
128 Nbe62af0d7c64409a930550b822499778
129 Nc1a0a998e64844b99706429e6bc60e80
130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142277542
131 https://doi.org/10.1186/s12933-021-01405-4
132 schema:sdDatePublished 2022-08-04T17:10
133 schema:sdLicense https://scigraph.springernature.com/explorer/license/
134 schema:sdPublisher N3b489c9ad2f949beb2bcf9384e606b39
135 schema:url https://doi.org/10.1186/s12933-021-01405-4
136 sgo:license sg:explorer/license/
137 sgo:sdDataset articles
138 rdf:type schema:ScholarlyArticle
139 N017fea96af404975ac102b1c7fda11c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Randomized Controlled Trials as Topic
141 rdf:type schema:DefinedTerm
142 N01d304291cb34d598943f034107b9850 rdf:first sg:person.01240141422.07
143 rdf:rest N4686effcf9484aa48a9e4d2e3c66418a
144 N084013bbefd44d28a382433244543958 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Treatment Outcome
146 rdf:type schema:DefinedTerm
147 N10e90714fb7144fbb0f492dd98ef4c10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Time Factors
149 rdf:type schema:DefinedTerm
150 N12b4fe64e9b04e3090cf26413d9c8f3b rdf:first sg:person.07360604275.78
151 rdf:rest N5f3f9dd06cbc4e4eb630ede01a5a560e
152 N275d1b13ff7346e3aee69a982ae81778 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Aged
154 rdf:type schema:DefinedTerm
155 N2873c3e0e6be465fafc2d3b3431ca390 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Coronary Artery Disease
157 rdf:type schema:DefinedTerm
158 N2886f262bb7b424da58282bd06aaf8b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Diabetes Mellitus
160 rdf:type schema:DefinedTerm
161 N2b7c91f9100f463286b9c4c45ce0cf1b rdf:first sg:person.0727014624.50
162 rdf:rest N5722c9909cfd429abb85fcecf7f45fe6
163 N330cf17e2de5492dbb6adf7bb1aef47f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Coronary Thrombosis
165 rdf:type schema:DefinedTerm
166 N3931e43d1f554acdbfae5eba5041939e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Drug-Eluting Stents
168 rdf:type schema:DefinedTerm
169 N3b489c9ad2f949beb2bcf9384e606b39 schema:name Springer Nature - SN SciGraph project
170 rdf:type schema:Organization
171 N3bf98fe86438447983f75d3b6cff545d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Middle Aged
173 rdf:type schema:DefinedTerm
174 N3fa16763c3a4454082c021ebc9cd673c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Prosthesis Design
176 rdf:type schema:DefinedTerm
177 N4686effcf9484aa48a9e4d2e3c66418a rdf:first sg:person.0752260563.26
178 rdf:rest Ne9d78da067a2491db6670136a2dbb7e1
179 N4e775834692b437380861eb80ff8a7b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Glycated Hemoglobin A
181 rdf:type schema:DefinedTerm
182 N5722c9909cfd429abb85fcecf7f45fe6 rdf:first sg:person.0634373652.04
183 rdf:rest N94564fa930a241de87c4ef25b7448f03
184 N5f3f9dd06cbc4e4eb630ede01a5a560e rdf:first sg:person.0624615067.52
185 rdf:rest N2b7c91f9100f463286b9c4c45ce0cf1b
186 N67bc17f9850447fda59d5de023b9c333 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Blood Glucose
188 rdf:type schema:DefinedTerm
189 N6a1b5980a7af4eb39bf16fa0f48ee9b1 rdf:first sg:person.0660011420.13
190 rdf:rest rdf:nil
191 N7438392cb38d46008a43644962417938 schema:issueNumber 1
192 rdf:type schema:PublicationIssue
193 N7d5949eb720d4e4eb1d701a9feae0f2e rdf:first sg:person.012437210704.63
194 rdf:rest N12b4fe64e9b04e3090cf26413d9c8f3b
195 N7dfb00bf94914bc1b89a79b3bee6ee31 schema:volumeNumber 20
196 rdf:type schema:PublicationVolume
197 N851a308fa258453a9cd5d68a0bb0c46e schema:name pubmed_id
198 schema:value 34717627
199 rdf:type schema:PropertyValue
200 N8a3cb52baa4f4a5cb1708ccb25e3b8aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Prediabetic State
202 rdf:type schema:DefinedTerm
203 N94564fa930a241de87c4ef25b7448f03 rdf:first sg:person.0730262371.12
204 rdf:rest N01d304291cb34d598943f034107b9850
205 Na3928d2c25e94be0ac1c31cdd50c4d28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Humans
207 rdf:type schema:DefinedTerm
208 Nad916d01da1941e6b0a6cd6436b9bcc8 rdf:first sg:person.0600054325.83
209 rdf:rest N6a1b5980a7af4eb39bf16fa0f48ee9b1
210 Naf3dfdffea5b45089b83d7763ccb0017 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Risk Factors
212 rdf:type schema:DefinedTerm
213 Nb7906a90eff441b3a9a71e1e663fa7b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Hypoglycemic Agents
215 rdf:type schema:DefinedTerm
216 Nbe62af0d7c64409a930550b822499778 schema:name doi
217 schema:value 10.1186/s12933-021-01405-4
218 rdf:type schema:PropertyValue
219 Nc1a0a998e64844b99706429e6bc60e80 schema:name dimensions_id
220 schema:value pub.1142277542
221 rdf:type schema:PropertyValue
222 Ndbdf9624e6f0489eb3e4dee35bf43d10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Percutaneous Coronary Intervention
224 rdf:type schema:DefinedTerm
225 Nde05527cbefb4630b37c0a18ea479592 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Male
227 rdf:type schema:DefinedTerm
228 Ne568574688064c5498905012e402e975 rdf:first sg:person.015002444531.78
229 rdf:rest N7d5949eb720d4e4eb1d701a9feae0f2e
230 Ne65afba2f7eb4b79b1922cc431c566db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
231 schema:name Risk Assessment
232 rdf:type schema:DefinedTerm
233 Ne9d78da067a2491db6670136a2dbb7e1 rdf:first sg:person.01146757520.17
234 rdf:rest Nad916d01da1941e6b0a6cd6436b9bcc8
235 Nea2e020e22dc46cb901a1c0c75721c2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
236 schema:name Female
237 rdf:type schema:DefinedTerm
238 Nf519c9f474fe41a48f0b5951a697f4c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
239 schema:name Hemorrhage
240 rdf:type schema:DefinedTerm
241 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
242 schema:name Medical and Health Sciences
243 rdf:type schema:DefinedTerm
244 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
245 schema:name Cardiorespiratory Medicine and Haematology
246 rdf:type schema:DefinedTerm
247 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
248 schema:name Clinical Sciences
249 rdf:type schema:DefinedTerm
250 sg:journal.1031021 schema:issn 1475-2840
251 schema:name Cardiovascular Diabetology
252 schema:publisher Springer Nature
253 rdf:type schema:Periodical
254 sg:person.01146757520.17 schema:affiliation grid-institutes:grid.6214.1
255 schema:familyName Doggen
256 schema:givenName Carine J. M.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17
258 rdf:type schema:Person
259 sg:person.01240141422.07 schema:affiliation grid-institutes:grid.413871.8
260 schema:familyName Aminian
261 schema:givenName Adel
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240141422.07
263 rdf:type schema:Person
264 sg:person.012437210704.63 schema:affiliation grid-institutes:grid.6214.1
265 schema:familyName Pinxterhuis
266 schema:givenName Tineke H.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012437210704.63
268 rdf:type schema:Person
269 sg:person.015002444531.78 schema:affiliation grid-institutes:grid.6214.1
270 schema:familyName Ploumen
271 schema:givenName Eline H.
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015002444531.78
273 rdf:type schema:Person
274 sg:person.0600054325.83 schema:affiliation grid-institutes:grid.6214.1
275 schema:familyName von Birgelen
276 schema:givenName Clemens
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83
278 rdf:type schema:Person
279 sg:person.0624615067.52 schema:affiliation grid-institutes:grid.6451.6
280 schema:familyName Roguin
281 schema:givenName Ariel
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624615067.52
283 rdf:type schema:Person
284 sg:person.0634373652.04 schema:affiliation grid-institutes:grid.413591.b
285 schema:familyName Schotborgh
286 schema:givenName Carl E.
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634373652.04
288 rdf:type schema:Person
289 sg:person.0660011420.13 schema:affiliation grid-institutes:grid.415214.7
290 schema:familyName Kok
291 schema:givenName Marlies M.
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13
293 rdf:type schema:Person
294 sg:person.0727014624.50 schema:affiliation grid-institutes:grid.491363.a
295 schema:familyName Anthonio
296 schema:givenName Rutger L.
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727014624.50
298 rdf:type schema:Person
299 sg:person.0730262371.12 schema:affiliation grid-institutes:grid.414977.8
300 schema:familyName Benit
301 schema:givenName Edouard
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730262371.12
303 rdf:type schema:Person
304 sg:person.07360604275.78 schema:affiliation grid-institutes:grid.415214.7
305 schema:familyName Zocca
306 schema:givenName Paolo
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07360604275.78
308 rdf:type schema:Person
309 sg:person.0752260563.26 schema:affiliation grid-institutes:grid.415930.a
310 schema:familyName Danse
311 schema:givenName Peter W.
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260563.26
313 rdf:type schema:Person
314 sg:pub.10.1007/s00592-015-0746-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039151013
315 https://doi.org/10.1007/s00592-015-0746-8
316 rdf:type schema:CreativeWork
317 sg:pub.10.1007/s40256-018-0295-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1106283437
318 https://doi.org/10.1007/s40256-018-0295-y
319 rdf:type schema:CreativeWork
320 sg:pub.10.1186/s12933-020-01173-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132950023
321 https://doi.org/10.1186/s12933-020-01173-7
322 rdf:type schema:CreativeWork
323 grid-institutes:grid.413591.b schema:alternateName Department of Cardiology, Haga Hospital, The Hague, Netherlands
324 schema:name Department of Cardiology, Haga Hospital, The Hague, Netherlands
325 rdf:type schema:Organization
326 grid-institutes:grid.413871.8 schema:alternateName Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium
327 schema:name Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium
328 rdf:type schema:Organization
329 grid-institutes:grid.414977.8 schema:alternateName Department of Cardiology, Jessa Hospital, Hasselt, Belgium
330 schema:name Department of Cardiology, Jessa Hospital, Hasselt, Belgium
331 rdf:type schema:Organization
332 grid-institutes:grid.415214.7 schema:alternateName Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands
333 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands
334 rdf:type schema:Organization
335 grid-institutes:grid.415930.a schema:alternateName Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands
336 schema:name Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands
337 rdf:type schema:Organization
338 grid-institutes:grid.491363.a schema:alternateName Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands
339 schema:name Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands
340 rdf:type schema:Organization
341 grid-institutes:grid.6214.1 schema:alternateName Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands
342 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands
343 Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands
344 rdf:type schema:Organization
345 grid-institutes:grid.6451.6 schema:alternateName Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel
346 schema:name Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel
347 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...